Yonezawa Taishi, Rutter Justine, Ramabadran Raghav, Sundaramurthy Venkatasubramaniam, Datar Gandhar, Slabicki Mikolaj, Goodell Margaret A
bioRxiv. 2025 May 15:2025.03.05.641683. doi: 10.1101/2025.03.05.641683.
DNA methyltransferase 3A (DNMT3A) plays crucial roles in hematopoiesis and mammalian development. DNMT3A protein instability has been associated with several diseases such as MDS, AML and Tatton-Brown-Rahman syndrome. Here we report, DNMT3A stability is maintained by deubiquitinating enzyme USP11 countering degradation by CUL4-DCAF8 E3 ligase. DNMT3A localization changes caused by certain unstable DNMT3A mutations, which could be considered one of the losses of function of DNMT3A. The mislocalization is partially rescued by E1 enzyme inhibition or stable USP11 expression lines. Interestingly, we show that USP11 enhances DNMT3A SUMOylation by promoting the interaction between DNMT3A and SUMO E3 Ligases, and DNMT3A SUMOylation also essential for maintaining DNMT3A protein stability and DNMT3A DNA Mtase activity. Our results reveal the mechanism for DNMT3A protein turnover through USP11, and the mechanism essential for DNMT3A function, as well as a therapeutic approach for several diseases causing DNMT3A protein instability.
DNA甲基转移酶3A(DNMT3A)在造血作用和哺乳动物发育过程中发挥着关键作用。DNMT3A蛋白的不稳定性与多种疾病相关,如骨髓增生异常综合征(MDS)、急性髓系白血病(AML)和塔顿-布朗-拉赫曼综合征。在此我们报告,去泛素化酶USP11可维持DNMT3A的稳定性,对抗CUL4-DCAF8 E3连接酶介导的降解。某些不稳定的DNMT3A突变会导致DNMT3A定位改变,这可被视为DNMT3A功能丧失之一。通过抑制E1酶或稳定的USP11表达系可部分挽救这种定位错误。有趣的是,我们发现USP11通过促进DNMT3A与SUMO E3连接酶之间的相互作用来增强DNMT3A的SUMO化,并且DNMT3A的SUMO化对于维持DNMT3A蛋白稳定性和DNMT3A DNA甲基转移酶活性也至关重要。我们的研究结果揭示了通过USP11实现DNMT3A蛋白周转的机制、DNMT3A功能所必需的机制,以及针对几种导致DNMT3A蛋白不稳定疾病的治疗方法。